Gaudium IVF and Women Health Limited, established in 2015, is a healthcare company specializing in fertility and reproductive treatments in India. Originally incorporated as a private company, it transitioned to a public limited entity in October 2024. The company operates over 30 locations across India, organized in a hub-and-spoke network, with 7 central hubs and 28 spokes. It collaborates strategically with infertility experts to expand awareness and availability of assisted reproductive technologies (ART) and IVF treatments.
Founded by Dr. Manika Khanna, the company focuses on advanced fertility treatments like In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), ovulation induction, and comprehensive gynecological care. Gaudium IVF addresses both male and female infertility challenges and provides specialized services for high-risk pregnancies, fertility wellness programs, and advanced procedures such as genetic testing, laparoscopic surgeries, and cryopreservation for fertility preservation.
The company has undergone key acquisitions to support its growth. In 2021, it acquired Dr. Manika Khanna's proprietary firm Gaudium IVF and Gynae Solutions, and in 2023, it acquired Gaudium International Private Limited and Gaudium Bawa Ludhiana Centre as a going concern. Recently, in 2024, the company launched new centers in Srinagar, Jammu & Kashmir, and Bangalore, Karnataka, reflecting its commitment to expanding across India.
Gaudium IVF is preparing for an initial public offering (IPO), with plans to issue 2,08,86,100 equity shares, consisting of a fresh issue and an offer for sale. The IPO aims to bolster its position as a leader in India's fertility treatment market, leveraging its advanced technology, holistic care approach, and extensive geographical footprint.
